Alan Rubinow

5.3k total citations
105 papers, 3.2k citations indexed

About

Alan Rubinow is a scholar working on Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan Rubinow has authored 105 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 26 papers in Rheumatology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan Rubinow's work include Amyloidosis: Diagnosis, Treatment, Outcomes (27 papers), Vasculitis and related conditions (10 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers). Alan Rubinow is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (27 papers), Vasculitis and related conditions (10 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers). Alan Rubinow collaborates with scholars based in Israel, United States and Australia. Alan Rubinow's co-authors include Alan S. Cohen, M Sonnenblick, Gideon Nesher, Rodney H. Falk, Yackov Berkun, Mario Baras, Mihaela Mates, Michael Skinner, Bartolomé R. Celli and Martha Skinner and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Alan Rubinow

105 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Rubinow Israel 30 1.4k 873 841 499 425 105 3.2k
Sedat Kiraz Türkiye 32 798 0.6× 889 1.0× 1.2k 1.4× 305 0.6× 150 0.4× 195 3.9k
İhsan Ertenli Türkiye 28 677 0.5× 554 0.6× 997 1.2× 219 0.4× 118 0.3× 155 2.7k
Thomas J A Lehman United States 35 648 0.5× 756 0.9× 1.6k 1.9× 299 0.6× 239 0.6× 106 4.2k
G Triolo Italy 41 1.1k 0.8× 644 0.7× 2.3k 2.7× 242 0.5× 652 1.5× 209 5.7k
Gökhan Keser Türkiye 28 475 0.3× 916 1.0× 891 1.1× 270 0.5× 244 0.6× 97 2.9k
Josep M. Grau Spain 32 444 0.3× 1.9k 2.2× 1.3k 1.6× 433 0.9× 297 0.7× 71 3.8k
Daniel Albert United States 26 535 0.4× 292 0.3× 1.2k 1.4× 1.0k 2.1× 125 0.3× 94 3.2k
Debashish Danda India 29 418 0.3× 1.2k 1.4× 1.1k 1.3× 548 1.1× 340 0.8× 180 3.1k
Ömer Karadağ Türkiye 26 580 0.4× 675 0.8× 940 1.1× 282 0.6× 109 0.3× 215 2.6k
Riccardo Melicòni Italy 33 448 0.3× 973 1.1× 1.6k 1.9× 103 0.2× 277 0.7× 137 3.5k

Countries citing papers authored by Alan Rubinow

Since Specialization
Citations

This map shows the geographic impact of Alan Rubinow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Rubinow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Rubinow more than expected).

Fields of papers citing papers by Alan Rubinow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Rubinow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Rubinow. The network helps show where Alan Rubinow may publish in the future.

Co-authorship network of co-authors of Alan Rubinow

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Rubinow. A scholar is included among the top collaborators of Alan Rubinow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Rubinow. Alan Rubinow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnson, Yoav, et al.. (2011). Association of fibromyalgia characteristics in patients with non-metastatic breast cancer and the protective role of resilience. Rheumatology International. 32(10). 3017–3023. 20 indexed citations
2.
Cohen, Matan J., et al.. (2011). Large Vessel (Takayasu's) Arteritis in a Patient With Myelodysplastic Syndrome: Is There a Common Pathogenesis?. Clinical Lymphoma Myeloma & Leukemia. 11(1). 60–63. 13 indexed citations
3.
Sviri, Sigal, Yaakov Garb, Alan Rubinow, et al.. (2009). Contradictions in end-of-life decisions for self and other, expressed by relatives of chronically ventilated patients. Journal of Critical Care. 24(2). 293–301. 15 indexed citations
4.
Leader, Avi, et al.. (2009). An Open‐label Study Adding Creatine Monohydrate to Ongoing Medical Regimens in Patients with the Fibromyalgia Syndrome. Annals of the New York Academy of Sciences. 1173(1). 829–836. 11 indexed citations
5.
Vishne, Tali, et al.. (2008). Fibromyalgia among major depression disorder females compared to males. Rheumatology International. 28(9). 831–836. 28 indexed citations
6.
Hershko, Alon Y., Yackov Berkun, Dror Mevorach, Alan Rubinow, & Yaakov Naparstek. (2008). Increased Intracranial Pressure Related to Systemic Lupus Erythematosus: A 26-year Experience. Seminars in Arthritis and Rheumatism. 38(2). 110–115. 24 indexed citations
7.
Golan, Itshak, Shlomo Nedvetzki, David Levartovsky, et al.. (2007). Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody. Journal of Autoimmunity. 28(2-3). 99–113. 16 indexed citations
8.
Lewis, E D, Peter Vernon van Heerden, Felicity Hawker, et al.. (2006). Equitable resource allocation in the intensive care unit: a descriptive ethical case. Critical Care and Resuscitation. 8(2). 123–128. 1 indexed citations
9.
Fostick, Leah, Michael Polliack, Shlomo Segev, et al.. (2006). Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities?. Journal of Psychosomatic Research. 61(5). 663–669. 65 indexed citations
10.
Rubinow, Alan, et al.. (2004). General Medicine practitioners’ attitudes towards “do not attempt resuscitation” orders. Resuscitation. 62(2). 181–187. 2 indexed citations
11.
Nesher, Gideon, Yackov Berkun, Mihaela Mates, et al.. (2004). Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis & Rheumatism. 50(4). 1332–1337. 267 indexed citations
12.
Amital, Howard, Suhail Aamar, & Alan Rubinow. (2003). BILATERAL SEPTIC ARTHRITIS OF THE HIP: DOES ETANERCEPT PLAY A ROLE?. Journal of Bone and Joint Surgery. 85(11). 2205–2206. 7 indexed citations
13.
Sonnenblick, M, Gideon Nesher, Y. Friedlander, & Alan Rubinow. (1994). GIANT CELL ARTERITIS IN JERUSALEM: A 12-YEAR EPIDEMIOLOGICAL STUDY. Lara D. Veeken. 33(10). 938–941. 73 indexed citations
14.
Putterman, Chaim & Alan Rubinow. (1993). Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Seminars in Arthritis and Rheumatism. 22(6). 420–426. 51 indexed citations
15.
Oren, Ran, Galina Pizov, Yaakov Naparstek, & Alan Rubinow. (1993). Colchicine induced remission in amyloid nephrotic syndrome. Clinical Rheumatology. 12(4). 532–534. 3 indexed citations
16.
Friedmann, A., A Markitziu, Eldad Ben‐Chetrit, et al.. (1993). Molecular analysis of HLA class II genes in primary sjo¨gren's syndrome. Human Immunology. 36(4). 235–242. 40 indexed citations
17.
Ben‐Chetrit, Eldad, Ruth Fischel, & Alan Rubinow. (1993). Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome. Clinical Rheumatology. 12(4). 471–474. 44 indexed citations
18.
Caraco, Yoseph & Alan Rubinow. (1992). Enhanced Anticoagulant Effect of Coumarin Derivatives Induced by Doxycycline Coadministration. Annals of Pharmacotherapy. 26(9). 1084–1086. 18 indexed citations
19.
Glikson, Michael, et al.. (1990). Anaplastic thyroid carcinoma in a retrosternal goiter presenting as fever of unknown origin. The American Journal of Medicine. 88(1). 81–82. 6 indexed citations
20.
Glikson, Michael, E. Galun, M Schlesinger, et al.. (1989). Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature.. PubMed. 16(4). 536–9. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sedat Kiraz Breakdown of academic impact, for papers by İhsan Ertenli Breakdown of academic impact, for papers by Thomas J A Lehman Breakdown of academic impact, for papers by G Triolo Breakdown of academic impact, for papers by Gökhan Keser Breakdown of academic impact, for papers by Josep M. Grau Breakdown of academic impact, for papers by Daniel Albert Breakdown of academic impact, for papers by Debashish Danda Breakdown of academic impact, for papers by Ömer Karadağ Breakdown of academic impact, for papers by Riccardo Melicòni
Rankless by CCL
2026